Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases

<p>Abstract</p> <p>Background</p> <p>Amphiregulin (AREG) and Epiregulin (EREG), ligands of EGFR, are reported to be predictive biomarkers of colorectal cancer patients treated with Cetuximab, an anti-EGFR antibody. The purpose of this study is to determine the correlation of AREG and EREG expression between primary colorectal cancer and corresponding liver metastases.</p> <p>Methods</p> <p>One hundred twenty colorectal cancer patients with liver metastases (100 with synchronous metastases, 20 with metachronous) were evaluated. No patients had ever received anti-EGFR antibody agents. AREG and EREG mRNA expression from both the primary tumor and liver metastases were measured using real-time RT-PCR. KRAS codon 12, 13 mutation status was analyzed by direct sequencing.</p> <p>Results</p> <p>Modest, but significant, correlations were observed between primary tumor and corresponding liver metastases in both AREG mRNA expression (Rs = 0.54, p < 0.0001) and EREG mRNA expression (Rs = 0.58, p < 0.0001). AREG and EREG mRNA expression was strongly correlated in both the primary tumor (Rs = 0.81, p < 0.0001) and the liver metastases (Rs = 0.87, p < 0.0001). No significant survival difference was observed between low and high AREG or EREG patients when all 120 patients were analyzed. However, when divided by KRAS status, KRAS wild-type patients with low EREG mRNA levels in the primary site showed significantly better overall survival rates than those with high levels (p = 0.018). In multivariate analysis, low EREG expression was significantly associated with better overall survival (p = 0.006).</p> <p>Conclusions</p> <p>AREG and EREG expression showed a modest correlation between primary tumor and liver metastases. As EREG mRNA expression was associated with decreased survival, it is appeared to be a useful prognostic marker in KRAS wild-type patients who never received anti-EGFR therapy.</p

A Solvation/Desolvation Indicator Based on van der Waals Interactions between Solvents and Porphyrins.

Solvation is a ubiquitous phenomenon associated with molecules in solutions. It often determines the equilibria of molecular systems and the rates of chemical reactions. Van der Waals interactions (a general term) includes weak interactions among noncharged compounds and it contributes significantly to solvation. The distinct observation of van der Waals interaction between solvent and porphyrin derivatives is reported herein. Bis(imidazolylporphyrinatozinc) structures connected through a 1,3-butadiyne moiety give two types of coordination polymers, E (extended) and S (stacked) polymers, exclusively. E polymers have larger solvent-accessible surface areas than the corresponding S polymers. Therefore, E polymers are better solvated than S polymers, providing an indicator of solvation and desolvation for the solvents used. A simple method (like a litmus test) was developed to evaluate the solvation ability of various solvents. Sixty-seven solvents and liquid compounds were tested, under the same conditions, using a conventional UV/Vis spectrometer. The results revealed a new liquid group with high solvation ability towards the porphyrins, and clarified van der Waals interaction assisted by secondary interaction on the substituents. The indicator system should contribute to the solution chemistry of molecules and materials, and to supramolecular chemistry interactions among hetero components.Solvation is a ubiquitous phenomenon associated with molecules in solutions. It often determines the equilibria of molecular systems and the rates of chemical reactions. Van der Waals interactions (a general term) includes weak interactions among noncharged compounds and it contributes significantly to solvation. The distinct observation of van der Waals interaction between solvent and porphyrin derivatives is reported herein. Bis(imidazolylporphyrinatozinc) structures connected through a 1,3-butadiyne moiety give two types of coordination polymers, E (extended) and S (stacked) polymers, exclusively. E polymers have larger solvent-accessible surface areas than the corresponding S polymers. Therefore, E polymers are better solvated than S polymers, providing an indicator of solvation and desolvation for the solvents used. A simple method (like a litmus test) was developed to evaluate the solvation ability of various solvents. Sixty-seven solvents and liquid compounds were tested, under the same conditions, using a conventional UV/Vis spectrometer. The results revealed a new liquid group with high solvation ability towards the porphyrins, and clarified van der Waals interaction assisted by secondary interaction on the substituents. The indicator system should contribute to the solution chemistry of molecules and materials, and to supramolecular chemistry interactions among hetero components

PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study

BACKGROUND: Several recent studies have reported that patients with metastatic colorectal cancer (CRC) whose primary tumor is located in left side of the colon have more favorable responses to anti-epidermal growth factor receptor (EGFR) antibody therapy than those with right-sided tumors. However, the mechanism for this phenomenon is unknown. METHODS: Fifty-two cases of primary CRC with liver metastases were analyzed in this retrospective study. The mRNA levels of 19 signal transduction genes in both primary tumor and liver metastases were measured by real-time reverse transcription polymerase chain reaction. The purposes of this study were (1) to determine the correspondence between signal transduction gene expressions in primary tumors and corresponding liver metastases, and (2) to determine whether expression levels of these genes differ by primary tumor location. RESULTS: mRNA expression levels of 14 of 19 signal transduction genes, including PTEN, ERBB2, MET, HGF, AREG, and EREG, showed significant correlations between the primary tumor and corresponding liver metastases. When the mRNA levels of the primary tumors were compared by tumor location, only PTEN mRNA expression differed significantly between left and right-sided CRC (median PTEN expression: left 1.00 vs. right 1.68; p = 0.017). When rectal cancers were separated from left-sided colon cancers, PTEN mRNA levels increased progressively from rectum to right-sided colon (median; rectum 0.84, left colon 1.23, right colon 1.68, p = 0.013). PTEN mRNA expression in liver metastases also differed significantly according to primary tumor location (median; left 0.92 vs. right 1.27, p = 0.048). There was no difference in overall survival between patients with high versus low levels of PTEN mRNA (p = 0.59). CONCLUSIONS: Our data suggest that the PIK3/AKT/mTOR pathway is more active in left- than right-sided CRC, which provides a possible explanation for the fact that efficacy of anti-EGFR therapy differs by location of primary tumor